Eckert & Ziegler SE (FRA:EUZ)

Market Cap	1.22B
Revenue (ttm)	296.43M
Net Income (ttm)	34.48M
Shares Out	n/a
EPS (ttm)	1.63
PE Ratio	35.31
Forward PE	24.25
Dividend	5.60 (9.48%)
Ex-Dividend Date	Jun 19, 2025

Volume	100
Average Volume	414
Open	59.15
Previous Close	59.10
Day's Range	59.15 - 59.45
52-Week Range	36.46 - 61.70
Beta	n/a
RSI	55.27
Earnings Date	May 13, 2025

About Eckert & Ziegler SE

Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; ophthalmological products; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynt...

• Industry: Industrial Inorganic Chemicals
• Founded: 2024
• Employees: 1,085
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: EUZ

Financial Performance

In 2024, Eckert & Ziegler SE's revenue was 295.85 million, an increase of 20.22% compared to the previous year's 246.09 million. Earnings were 33.28 million, an increase of 26.52%.